✦ Plain-English Summary

Export Control Legislation Amendment (Certification of Narcotic Exports) 2020

What it does

Australia's export control laws previously excluded narcotic drugs from their rules. This bill removes that exclusion, meaning narcotic goods are now treated like other exports and subject to the same export control requirements. It updates two key laws (the Export Control Act 1982 and 2020) to make this change consistent across both.

Why it matters

This gives the government clearer legal authority to regulate and certify the export of narcotic drugs—particularly important for Australia's legitimate pharmaceutical industry, which produces morphine, codeine, and other pain medications for global medical use. Without this fix, there was legal ambiguity about whether export controls actually applied to these medicines.

Key details

• When it started: The day after it received Royal Assent (late 2020)
• What changed: Removed the old rule that said narcotic goods didn't have to follow export control laws
• Who's affected: Australian pharmaceutical companies exporting narcotic medicines, and government agencies (like the Department of Agriculture) that approve and certify these exports
• No new penalties: This is a technical fix to align the laws—it doesn't create new offences or fines, just clarifies existing powers

Official Description

Amends the Export Control Act 1982 and Export Control Act 2020 to allow for the export of certain narcotic goods, such as medicinal cannabis and low-tetrahydrocannibinol hemp products.

No formal division recorded

This bill passed by voice vote — parliament agreed without calling a formal count. A division is only recorded when a member explicitly requests one.

No votes yet.

No votes were recorded for this bill.